147 related articles for article (PubMed ID: 7535464)
1. Quality assurance in flow cytometry: comparison of three analytical methods for quantifying CD34+ cells in marrow.
Yu M; Cottler-Fox M
Prog Clin Biol Res; 1994; 389():729-36. PubMed ID: 7535464
[No Abstract] [Full Text] [Related]
2. A semi-automated process for antibody sensitization and washing of mononuclear cells prior to CD34+ cell selection.
Cipolone KM; Carter CS; Yu M; Cottler-Fox M
Prog Clin Biol Res; 1994; 389():667-73. PubMed ID: 7535463
[No Abstract] [Full Text] [Related]
3. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
4. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M
Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439
[No Abstract] [Full Text] [Related]
5. Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantation.
Egeland T; Tjønnfjord G; Steen R; Gaudernack G; Thorsby E
Transplant Proc; 1993 Feb; 25(1 Pt 2):1261-3. PubMed ID: 7680152
[No Abstract] [Full Text] [Related]
6. CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.
Laughlin MJ; Christiansen NP; Herzig GP; Blumenson L; Bonney D; Stewart CC
Cytometry; 1996 Dec; 26(4):235-42. PubMed ID: 8979021
[TBL] [Abstract][Full Text] [Related]
7. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
8. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
9. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
Chang Q; Harvey K; Akard L; Thompson J; Dugan MJ; English D; Jansen J
Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064
[TBL] [Abstract][Full Text] [Related]
10. Separation of clinical quantities of CD34+ cells from human marrow using immunomagnetic procedures.
Burgess J; Traycoff C; Hardwick A; Smith A; Hangoc G; Ishizawa L; Moubayed M; Broun R; Srour E; Gee A
Prog Clin Biol Res; 1994; 389():293-302. PubMed ID: 7535434
[No Abstract] [Full Text] [Related]
11. Stem cell selection for autologous bone marrow transplantation.
Okarma TB
Semin Hematol; 1992 Apr; 29(2 Suppl 1):9-20. PubMed ID: 1377406
[No Abstract] [Full Text] [Related]
12. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG
Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937
[No Abstract] [Full Text] [Related]
13. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow.
Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031
[No Abstract] [Full Text] [Related]
14. Automated processing of human vertebral body bone marrow yields preparations with stem cell content similar to that obtained with traditional manual preparation.
Kenyon NS; Xu XM; Knapp J; Selvaggi GS; Bottino R; Kong SS; Qian T; Linetsky E; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3418. PubMed ID: 8540030
[No Abstract] [Full Text] [Related]
15. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
16. Single platform enumeration of viable CD34(pos) cells.
Keeney M; Brown W; Gratama J; Papa S; Lanza F; Sutherland DR;
J Biol Regul Homeost Agents; 2003; 17(3):247-53. PubMed ID: 14524610
[No Abstract] [Full Text] [Related]
17. Quality control for peripheral stem cell collection: the Ottawa experience.
Giulivi A; Huebsch LB; Van der Jagt R; Markman S; Fuller V; Birch P; Demone J; McDiermid S; Rutherford B
Prog Clin Biol Res; 1994; 389():753-9. PubMed ID: 7535465
[No Abstract] [Full Text] [Related]
18. Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients.
Siena S; Bregni M; Gianni AM
Exp Hematol; 1993 Feb; 21(2):203-5. PubMed ID: 7678809
[No Abstract] [Full Text] [Related]
19. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.
Orfao A; Escribano L; Villarrubia J; Velasco JL; Cerveró C; Ciudad J; Navarro JL; San Miguel JF
Am J Pathol; 1996 Nov; 149(5):1493-9. PubMed ID: 8909239
[TBL] [Abstract][Full Text] [Related]
20. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
